Wake Forest Univesity Health Sciences
Winston-Salem, North Carolina, 27157, United States
NCT Number: NCT04663061
The study team will study the efficacy of a high intensity medical weight loss intervention paired with a digital platform to create weight loss and induce remission of type 2 diabetes mellitus (T2DM) compared to a diabetes self-management education intervention. The digital platform provides the capability to tailor the treatment plan, provide automated support, and alert providers when a participant may need more support from the clinical team. If shown to be efficacious, this research could be highly impactful, causing us to rethink our approach to care for those with T2DM and shift the paradigm for millions of individuals in the United States. Furthermore, this approach will demonstrate the feasibility of helping people engage in metabolic treatment strategies in a way that is scalable leveraging digital and mobile solutions that extend the patient-provider relationship, shift care from episodic approaches to more of an on-going model that extends into the life of the patient, while also integrated within the healthcare system workflows.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Winston-Salem, North Carolina, 27157, United States
This project will determine if a data-assisted, high intensity medical weight loss intervention (HIWL) will lead to significant weight loss and diabetes remission in individuals with a Body Mass Index (BMI) 30-39.9 kg/m2 with T2DM of less than 6 years as compared to a diabetes self-management education intervention (DSME). Complete diabetes remission is considered to be achieved when the patient is not taking any anti-diabetes medication for at least 12 months, and the Glycated Hemoglobin (HbA1c) is < 5.7%. Partial remission is achieved when the patient is not taking any anti-diabetes medication and has an HbA1c of 5.7-6.4% for at least 12 months.Using a randomized controlled study design, we will randomly assign 90 participants to HIWL, HIWL + continuous glucose monitoring (CGM), or DSME. Participants assigned to HIWL will receive a high intensity behavioral weight loss intervention delivered using a digital patient engagement platform. Participants will be prescribed a low calorie dietary plan and a recommended physical activity program designed to produce 15-20% weight loss over 12 months. Those assigned to HIWL + CGM will receive the same intervention as HIWL; in addition we will provide them with CGM to use as part of their remote monitoring on a daily basis. Those assigned to DSME will participate in a comprehensive diabetes education program designed to provide education and skills for optimal diabetes management plus lifestyle modification counseling to produce 5% weight loss over the same timeframe. The primary outcome of weight loss will be assessed at 12 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion:
Exclusion criteria
Participants will be prescribed intensive medical weight loss with the goal of achieving 15% weight loss from initial weight
Participants will receive standard of care diabetes education
Participants will use CGM devices to track blood glucose levels in near real time
Time frame: baseline through 12 months
Change in weight from baseline
Time frame: baseline through 12 months
Change in hemoglobin A1c
Time frame: 12 months
Number of participants achieving A1c <6.5% and no anti-diabetes medications
Time frame: baseline and month 12
Average time spent at an average glucose of 100 mg/dL or lower collected by FreeStyle Libre.
Time frame: baseline through 12 months
Average time spent at a post-meal glucose level of 110 mg/dL or lower collected by FreeStyle Libre.
Time frame: baseline through 12 months
Average time spent in normal fasting glucose between 72-85 mg/dL collected by FreeStyle Libre.
Time frame: baseline and month 12
Number of episodes hypoglycemia (<70 mg/dL) episodes collected by FreeStyle Libre.
Time frame: baseline and month 12
Coefficient of variance collected by FreeStyle Libre.
Time frame: baseline and 12 months
Average glucose (mg/dL) collected by FreeStyle Libre.
Time frame: baseline, 3 months, 6 months, and 12 months
kilocalories averaged across 3 days
Time frame: baseline, 3 months, 6 months, and 12 months
%Carbohydrate/Fat/Protein; averaged across 3 days
Time frame: baseline, 3 months, 6 months, and 12 months
averaged across 3 days
Time frame: baseline, 3 months, 6 months, and 12 months
A validated summary measure of dietary quality, rated on a 100-point scale with a higher score denoting better diet quality
Time frame: baseline, 3 months, 6 months, and 12 months
Collected by pedometer over 7 days during each period. At the end of the 7th day, participants will record the final step count, and return the pedometer to the study team via a pre-stamped mail envelope.
Time frame: from baseline to month 12
The EuroQol's EQ-5D-5L will be used to measure quality of life. This instrument takes responses to five questions on mobility, self-care, ability to perform usual activities, pain, and anxiety/depression to produce a validated quality score. Total score range is 5-25 with a lower score indicating a better quality of life.
Time frame: from baseline to month 12
The EuroQol's EQ-5D-5L visual analog scale will be used to measure participants perceived health. On a scale of 0-100 participants will rate their health. 0 means the worst health you can imagine. 100 means the best health you can imagine.
Time frame: baseline, 3 months, 6 months, and 12 months
A validated self-report measure of daily physical activity levels. Responses are given as minutes per day over the last week of walking for exercise. Outcome is average total minutes/week.
Time frame: baseline, 3 months, 6 months, and 12 months
A validated self-report measure of daily physical activity levels. Responses are given as minutes per day over the last week of sitting time. Outcome is average total minutes/week.
Time frame: baseline, 3 months, 6 months, and 12 months
A validated self-report measure of daily physical activity levels. Responses are given as minutes per day over the last week of moderate and vigorous physical activity. Outcome is average total minutes/week.
Wake Forest University Health Sciences
Other
Data-Assisted Approach for High Intensity Medical Weight Loss for Diabetes Remission
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05935514
Body Weight, Diabetes Mellitus
Stanford, California, United States
View Trial DetailsNCT04114903
Body Weight, Cannabis Use
Boulder, Colorado, United States
View Trial DetailsNCT01667783
Body Weight, Diabetes Mellitus
Baltimore, Maryland, United States
View Trial DetailsNCT01693406
Behavior, Body Weight
Aurora, Colorado, United States
View Trial Details